LONDON--(Marketwire - May 25, 2010) - StayinFront, Inc., a leading global provider of CRM and decision support solutions, today announced that Mepha Baltic, SIA, an affiliate of the innovative Swiss pharmaceutical company, Mepha Ltd., will deploy the latest version of StayinFront Life Sciences. The leading company in the Swiss generic drug market, Mepha develops and produces pharmaceuticals and over-the-counter medical products and exports its pharmaceuticals to more than 50 countries worldwide.
Mepha sought the StayinFront solution because it was looking for an effective way to target customers for both the pharmaceutical and OTC markets. They were also challenged by the inability to analyze the impact of promotional activities on sales. StayinFront's powerful built-in analytics will help Mepha to gain valuable insight into their customer data, and its Marketing Center module will strengthen Mepha's integrated marketing capabilities and help solidify implementation of a new two-dimensional targeting strategy.
"The StayinFront system gives us a broad range of functionality that will support our sales efforts and provide us with the opportunity to gain insight into promotional buys that work to our advantage," stated Agita Lazdina, Mepha Baltic Regional Manager. "There aren't many vendors that support both the pharmaceutical and OTC marketplace, so StayinFront was a clear choice for us."
Wayne Gallaway, vice president of StayinFront EMEA Sales, said, "We are pleased that Mepha has recognized our unique ability to provide a reliable platform for performing marketing initiatives across various sales channels, including pharmacists, chains, general practitioners and specialists. We look forward to a long and successful relationship and are confident that we can help Mepha meet its objectives in the global marketplace."
StayinFront Life Sciences' helps companies secure and grow product market share at the physician and hospital account levels. The flexible solution supports various field teams and helps identify and leverage key opinion leader (KOL) relationships. In addition, StayinFront can provide the entire solution -- from software to infrastructure to support services -- with the assurance of the support of experts in the field of pharmaceutical CRM.
For more details about the latest version of the StayinFront CRM solutions or to experience an online demonstration, please visit stayinfront.com.
About Mepha Ltd.
Mepha is the leading company in the Swiss generic market and has a strong presence in all distribution channels (pharmacists, medical doctors, hospitals). Mepha develops and produces medical products and services in Switzerland to enable doctors and pharmacists to treat their patients with effectiveness and cost awareness. Mepha's innovative galenics are more readily accepted by patients, so the patient compliance is higher, which makes for a more effective treatment. Mepha exports its pharmaceuticals to more than 50 countries, such as the Baltic States, Poland, Portugal in Europe, to Middle East countries, to West and East-Africa and to Southern and Central America.
About StayinFront
For over 20 years, StayinFront has been a global leader in the development, delivery and support of leading CRM and decision support tools. From new products such as Edge and Web Detailing to the full suite of online and offline solutions, StayinFront's innovative technology helps increase sales force effectiveness while delivering robust performance and flexibility. On-demand or on-premise, StayinFront provides the rich functionality, fast deployment and easy to use tools that your teams need to sell more and manage better.
StayinFront has been chosen globally as a strategic partner by many of the world's top life sciences, consumer goods, financial services and business-to-business companies and StayinFront solutions have been implemented in over 65 countries in 25 languages.
Headquartered in Fairfield, New Jersey, StayinFront has offices in Illinois, the United Kingdom, Ireland, India, Australia, Singapore and New Zealand. For more information, visit www.stayinfront.com.